Johnson Financial Group Inc. Sells 2,197 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Johnson Financial Group Inc. lowered its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 23.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,268 shares of the company’s stock after selling 2,197 shares during the period. Johnson Financial Group Inc.’s holdings in Henry Schein were worth $550,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently made changes to their positions in the company. McGlone Suttner Wealth Management Inc. bought a new position in Henry Schein during the 4th quarter worth $39,000. Neo Ivy Capital Management bought a new position in Henry Schein during the 3rd quarter worth $46,000. Covestor Ltd increased its stake in Henry Schein by 22.8% during the 3rd quarter. Covestor Ltd now owns 1,367 shares of the company’s stock worth $102,000 after acquiring an additional 254 shares during the period. Benjamin F. Edwards & Company Inc. increased its stake in Henry Schein by 37.8% during the 4th quarter. Benjamin F. Edwards & Company Inc. now owns 1,516 shares of the company’s stock worth $114,000 after acquiring an additional 416 shares during the period. Finally, GAMMA Investing LLC bought a new position in Henry Schein during the 4th quarter worth $115,000. Institutional investors own 96.62% of the company’s stock.

Insider Buying and Selling

In related news, CEO Bradford C. Connett sold 6,430 shares of the firm’s stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total transaction of $477,620.40. Following the completion of the transaction, the chief executive officer now directly owns 73,108 shares of the company’s stock, valued at approximately $5,430,462.24. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, Vice Chairman James P. Breslawski sold 2,907 shares of Henry Schein stock in a transaction dated Monday, March 18th. The stock was sold at an average price of $74.37, for a total value of $216,193.59. Following the completion of the transaction, the insider now directly owns 209,562 shares of the company’s stock, valued at approximately $15,585,125.94. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Bradford C. Connett sold 6,430 shares of Henry Schein stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total value of $477,620.40. Following the completion of the transaction, the chief executive officer now directly owns 73,108 shares of the company’s stock, valued at $5,430,462.24. The disclosure for this sale can be found here. 1.14% of the stock is owned by corporate insiders.

Henry Schein Price Performance

Shares of NASDAQ HSIC traded up $0.20 during mid-day trading on Friday, hitting $71.72. 458,504 shares of the stock traded hands, compared to its average volume of 1,089,650. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.75 and a quick ratio of 1.02. Henry Schein, Inc. has a twelve month low of $60.01 and a twelve month high of $82.63. The company has a market cap of $9.18 billion, a PE ratio of 24.23, a price-to-earnings-growth ratio of 1.80 and a beta of 0.87. The firm has a 50 day simple moving average of $72.49 and a two-hundred day simple moving average of $72.96.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, May 7th. The company reported $1.10 earnings per share for the quarter, beating the consensus estimate of $1.01 by $0.09. The company had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.21 billion. Henry Schein had a return on equity of 13.51% and a net margin of 3.12%. Henry Schein’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same quarter last year, the business posted $1.21 EPS. As a group, equities research analysts forecast that Henry Schein, Inc. will post 5.08 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

HSIC has been the topic of a number of recent research reports. Barrington Research raised their price objective on Henry Schein from $90.00 to $92.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 8th. Evercore ISI raised their target price on Henry Schein from $79.00 to $83.00 and gave the company an “in-line” rating in a report on Wednesday, February 28th. Jefferies Financial Group raised their target price on Henry Schein from $74.00 to $81.00 and gave the company a “hold” rating in a report on Wednesday, March 6th. JPMorgan Chase & Co. raised their target price on Henry Schein from $82.00 to $88.00 and gave the company an “overweight” rating in a report on Wednesday, March 6th. Finally, SVB Leerink assumed coverage on Henry Schein in a report on Monday, February 26th. They issued a “market perform” rating and a $78.00 target price on the stock. One analyst has rated the stock with a sell rating, six have given a hold rating and five have given a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $81.73.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.